Spruce Biosciences (NASDAQ:SPRB) just reported results for the second quarter of 2024.
- Spruce Biosciences reported earnings per share of -22 cents. This was above the analyst estimate for EPS of -30 cents.
- The company reported revenue of $1.61 million.
- This was 7.69% better than the analyst estimate for revenue of $1.50 million.